Related references
Note: Only part of the references are listed.UAP1L1 plays an oncogene-like role in glioma through promoting proliferation and inhibiting apoptosis
Zhuanyi Yang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2021)
TATTON: a multi-arm, phase lb trial of osimertinib combined with selumetinib, savolitinib, or durvalumab in EGFR-mutant lung cancer
G. R. Oxnard et al.
ANNALS OF ONCOLOGY (2020)
TBtools: An Integrative Toolkit Developed for Interactive Analyses of Big Biological Data
Chengjie Chen et al.
MOLECULAR PLANT (2020)
Swiss Target Prediction: updated data and new features for efficient prediction of protein targets of small molecules
Antoine Daina et al.
NUCLEIC ACIDS RESEARCH (2019)
GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2019)
SubCellBarCode: Proteome-wide Mapping of Protein Localization and Relocalization
Lukas Minus Orre et al.
MOLECULAR CELL (2019)
Current status and potential challenges of mesenchymal stem cell-based therapy for malignant gliomas
Qing Zhang et al.
STEM CELL RESEARCH & THERAPY (2018)
Selumetinib Plus Docetaxel Compared With Docetaxel Alone and Progression-Free Survival in Patients With KRAS-Mutant Advanced Non-Small Cell Lung Cancer The SELECT-1 Randomized Clinical Trial
Pasi A. Janne et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
miR-93 Promotes Cell Proliferation in Gliomas through Activation of PI3K/Akt Signaling Pathway
Lili Jiang et al.
ONCOTARGET (2015)
Cytoscape: A software environment for integrated models of biomolecular interaction networks
P Shannon et al.
GENOME RESEARCH (2003)
Share Paper
